Autopsy report · NCT01299922

Clinical Trial Treatment in Lupus Nephritis

“IT was impossible to find patients”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Hospital Universitario Fundación Alcorcón

Sponsor type

University, hospital or other

Conditions

Lupus Nephritis

Interventions

cyclosporine +mycophenolic acid+prednison; Mycophenolic Acid + prednison

Participants

0

Sites

1

Countries

Spain

Trials that died the same way

• A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
  “Unable to recruit patients.” (74% match in meaning)
• Non-invasive Improvement of Buttocks With Magnetic Device
  “It wasn't possible to recruit the desired number of patients.” (72% match in meaning)
• A Single-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-L10D Cell Formulations Targeting CD19 and CD22 in Patients With CD19- and/or CD22-Positive Relapsed/Refractory B-cell Lymphoma
  “Suitable patients were not recruited” (72% match in meaning)
• Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold Granulomas
  “Was not able to recruit patients for randomization.” (72% match in meaning)
• Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
  “Could not enroll enough patients.” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.